ACC Completes Hospital Selection in Their Innovative Patient Navigator Program


Meredith Hemler

The American College of Cardiology (ACC) has announced that 20 hospitals from across the country have been selected to participate in the ACC Patient Navigator Program, rounding out the 35 total hospitals in the program.

This innovative initiative, which has already launched in 15 hospitals, is designed to provide participating hospitals with training and resources to establish navigator teams charged with coordinating personalized support for patients diagnosed with acute coronary syndrome (ACS), including heart attack, and heart failure (HF) during their hospital stay and in the weeks following their discharge when they are most vulnerable.

AstraZeneca is proud to be the Founding Sponsor to support this ACC initiative. We are the first company to provide large-scale funding for this type of national, cardio-focused patient navigator program.

“It is an exciting milestone to see all 35 hospitals enrolled in the ACC Patient Navigator Program because now more patients and caregivers will have access to the support and services provided by the Patient Navigator teams in hospitals across the country,” said Gregory F. Keenan, M.D., Vice President and U.S. Head Medical Officer, AstraZeneca. “At AstraZeneca, we know that cardiovascular disease impacts each patient differently, and the needs of patients and caregivers are distinct and personal following a heart attack. That’s why we’re proud to be the founding sponsor of this program, and our hope is that supporting initiatives like this can help make a meaningful difference for patients and their families.”

According to the ACC, they have carefully chosen a diverse group of hospitals from across the country to participate in their program, representing a broad patient population and hospital treatment approaches to cardiac care.

The 20 newly selected hospitals include:

  • Aurora BayCare Medical Center, Green Bay, WI
  • Baptist Health Louisville, Louisville, KY
  • Barnes-Jewish Hospital at Washington University Medical Center, St. Louis, MO
  • California Pacific Medical Center, San Francisco, CA
  • Centra Lynchburg General Hospital, Lynchburg, VA
  • Fairview Hospital, Cleveland, OH
  • Indian River Medical Center, Vero Beach, FL
  • Mercy Hospital, Portland, ME
  • Mercy Medical Center, Des Moines, IA
  • Newark Beth Israel Medical Center, Newark, NJ
  • Olathe Medical Center, Olathe, KS
  • Renown Regional Medical Center, Reno, NV
  • Vincent’s Medical Center, Bridgeport, CT
  • Tacoma General Hospital, Tacoma, WA
  • University of Colorado Hospital, Aurora, CO
  • University of Utah, Salt Lake City, UT
  • UT Southwestern Medical Center, Dallas, TX
  • West Jefferson Medical Center, Marrero, LA
  • Western Maryland Health System, Cumberland, MD
  • Wyoming Medical Center, Casper, WY

The 15 previously selected hospitals include:

  • Advocate Sherman Hospital, Elgin, IL
  • Christiana Care Health Services, Wilmington, DE
  • Einstein Medical Center Philadelphia, Philadelphia, PA
  • Indiana University Health Methodist Hospital, Indianapolis, IN
  • MedStar Washington Hospital Center, Washington, DC
  • Providence St. Vincent Medical Center, Portland, OR
  • Ronald Reagan UCLA Medical Center, Los Angeles, CA
  • Mary’s Hospital, Waterbury, CT
  • Trident Health, Charleston, SC
  • Vanderbilt Heart and Vascular Institute, Nashville, TN
  • WakeMed Health and Hospital, Raleigh, NC
  • Scott & White Healthcare, Temple, TX
  • VCU Pauley Heart Center VCU Medical Center, Richmond, VA
  • Montefiore Medical Center, New York, NY
  • Huntsville Hospital, Huntsville, AL

As cardiovascular leaders, this program aligns with AstraZeneca’s commitment to patients and finding novel approaches to improving cardiovascular care.